Signaling pathways in pheochromocytomas and paragangliomas: prospects for future therapies.
There is currently no completely effective therapy available for metastatic pheochromocytomas or paragangliomas. Increasing understanding of the germline and somatic mutations leading to pheochromocytoma and paraganglioma development has revealed crucial insights into the molecular pathology of thes...
主要な著者: | Nölting, S, Grossman, AB |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2012
|
類似資料
-
Pheochromocytomas and paragangliomas: assessment of malignant potential.
著者:: Korevaar, T, 等
出版事項: (2011) -
Pheochromocytomas and paragangliomas: assessment of malignant potential
著者:: Korevaar, T, 等
出版事項: (2011) -
Current management of pheochromocytoma/paraganglioma: a guide for the practicing clinician in the era of precision medicine
著者:: Nölting, S, 等
出版事項: (2019) -
Pheochromocytomas and secreting paragangliomas
著者:: Gimenez-Roqueplo Anne-Paule, 等
出版事項: (2006-12-01) -
Treatment of metastatic pheochromocytoma and paraganglioma with I-131-meta-iodobenzylguanidine (MIBG)
著者:: Kaltsas, G, 等
出版事項: (2003)